Palisade Bio
Company

Palisade Bio

Pharmaceutical Manufacturing 7750 El Camino Real 15 employees PALI
Employees
15
Contacts
4
Emails
4
Phones
1

Palisade Bio Overview

Headquarters
7750 El Camino Real
Industry
Pharmaceutical Manufacturing
Employees
15
Founded
2005
Stock Symbol
PALI
Funding
3.9M
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing

About Palisade Bio

Palisade Bio (Nasdaq: PALI) is a biopharmaceutical company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. The Company believes that addressing the disruption of the intestinal barrier can fundamentally change the way diseases are treated and establish new standards of patient care. Palisade Bio’s lead program, PALI-2108 is a microbiota-activated PDE4 inhibitor prodrug being developed for the treatment of moderate-to-severe ulcerative colitis and is advancing toward the completion of IND-enabling studies and an IND filing. The Company’s second lead program, PALI-1908, is being evaluated in preclinical development for the treatment of fibrostenotic Crohn’s Disease.

Palisade Bio Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
1
25.0% coverage

Palisade Bio Org Chart

Sample employees and titles
Name Title Contact
J.d. Finley Chief Executive Officer at Palisade
Email
Ryker Willie Senior Vice President, Finance
Email Phone
William Fairchild Founding Member & Board Member at Eppic
Email
Mitchell L. Jones Chief Medical Officer - Md Clinical
Email

Employees by Management Level

Executive 3 profiles
Individual contributor 1 profile

Compare Similar Companies to Palisade Bio